BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells (Q39127080)

9 September 2017

title

BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells (English)

1 reference

(E)-3-(p-toluenesulfonyl)acrylonitrile

9 September 2017

main subject

1 reference

ChEBI release 2020-05-28

Xinyu Qin

1 reference

9 September 2017

Lingqiang Min

1 reference

9 September 2017

Ling Chen

1 reference

9 September 2017

Yuanyuan Ruan

1 reference

9 September 2017

Xuefei Wang

1 reference

9 September 2017

Zhenbin Shen

1 reference

9 September 2017

Yihong Sun

1 reference

9 September 2017

publication date

12 July 2013

1 reference

Journal of Gastroenterology

9 September 2017

published in

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

864-874

1 reference

9 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

7th Edition of the AJCC Cancer Staging Manual: Stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Molecular targeted agents for gastric and gastroesophageal junction cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

NF-κB and the link between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Regulation of NF-κB by ubiquitination and degradation of the IκBs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Nuclear factor-kappaB dependency of doxorubicin sensitivity in gastric cancer cells is determined by manganese superoxide dismutase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

NFκB inhibitors induce cell death in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by 131I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Antitumor effects and drug interactions of the proteasome inhibitor bortezomib (PS341) in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Modulation of activation-induced cytidine deaminase by curcumin in Helicobacter pylori-infected gastric epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Inhibition of nuclear factor‐kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Dueling activities of AIF in cell death versus survival: DNA binding and redox activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Caspases and kinases in a death grip

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Programmed cell death in animal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Mitochondria and cell death: outer membrane permeabilization and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

NF-kappaB and IKK as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Synthesis and structure-activity relationships of novel IKK-beta inhibitors. Part 2: Improvement of in vitro activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Proteasome inhibition as a new therapeutic principle in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Optimal dithiocarbamate structure for immunomodulator action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Nitric oxide acts as an antioxidant and delays programmed cell death in barley aleurone layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0848-4

The ubiquitin-proteasome pathway and enhanced activity of NF-kappaB in gastric carcinoma

21 January 2018

1 reference

12 December 2020

Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue

1 reference

12 December 2020

Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells

1 reference

12 December 2020

NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.

1 reference

12 December 2020

Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium

1 reference

12 December 2020

10.1007/S00535-013-0848-4

Identifiers

DOI

1 reference

9 September 2017

1 reference